UiPath, Inc. (NYSE:PATH - Get Free Report) CEO Daniel Dines sold 122,734 shares of UiPath stock in a transaction dated Wednesday, October 8th. The shares were sold at an average price of $14.89, for a total value of $1,827,509.26. Following the completion of the transaction, the chief executive officer directly owned 736,404 shares of the company's stock, valued at $10,965,055.56. This represents a 14.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Daniel Dines also recently made the following trade(s):
- On Monday, October 6th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $14.24, for a total value of $1,747,717.92.
- On Wednesday, October 1st, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $13.33, for a total value of $1,636,030.89.
- On Monday, September 29th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $12.33, for a total value of $1,513,297.89.
- On Friday, September 26th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $12.08, for a total value of $1,482,614.64.
- On Wednesday, September 24th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $12.44, for a total value of $1,526,798.52.
- On Monday, September 22nd, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $12.20, for a total value of $1,497,342.60.
- On Friday, September 19th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $11.92, for a total value of $1,462,977.36.
- On Wednesday, September 17th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $11.71, for a total value of $1,437,203.43.
- On Wednesday, September 10th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.01, for a total value of $540,450.00.
- On Thursday, July 31st, Daniel Dines sold 9,988 shares of UiPath stock. The stock was sold at an average price of $12.00, for a total value of $119,856.00.
UiPath Stock Up 5.2%
PATH stock traded up $0.77 during midday trading on Wednesday, reaching $15.59. The stock had a trading volume of 34,459,771 shares, compared to its average volume of 13,021,812. The business has a fifty day simple moving average of $11.67 and a two-hundred day simple moving average of $11.91. The firm has a market cap of $8.28 billion, a price-to-earnings ratio of 519.67, a PEG ratio of 5.37 and a beta of 1.07. UiPath, Inc. has a twelve month low of $9.38 and a twelve month high of $15.93.
UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.15 EPS for the quarter, topping analysts' consensus estimates of $0.08 by $0.07. The firm had revenue of $361.73 million during the quarter, compared to analyst estimates of $347.36 million. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The company's revenue was up 14.6% on a year-over-year basis. During the same period last year, the company earned $0.04 earnings per share. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, equities analysts predict that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.
Institutional Investors Weigh In On UiPath
Several institutional investors have recently bought and sold shares of the company. Patriot Financial Group Insurance Agency LLC lifted its stake in UiPath by 249.2% in the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 75,050 shares of the company's stock valued at $1,004,000 after acquiring an additional 53,555 shares in the last quarter. Silverberg Bernstein Capital Management LLC bought a new stake in UiPath in the 3rd quarter valued at approximately $165,000. Graphene Investments SAS lifted its stake in UiPath by 4.4% in the 3rd quarter. Graphene Investments SAS now owns 224,600 shares of the company's stock valued at $3,005,000 after acquiring an additional 9,400 shares in the last quarter. American Trust bought a new stake in shares of UiPath during the 2nd quarter worth approximately $148,000. Finally, Total Investment Management Inc. bought a new stake in shares of UiPath during the 2nd quarter worth approximately $108,000. Institutional investors own 62.50% of the company's stock.
Wall Street Analysts Forecast Growth
PATH has been the subject of several analyst reports. Cowen restated a "hold" rating on shares of UiPath in a research report on Friday, September 5th. Zacks Research upgraded UiPath from a "hold" rating to a "strong-buy" rating in a research report on Monday, September 8th. BMO Capital Markets boosted their target price on UiPath from $12.50 to $13.00 and gave the stock a "market perform" rating in a research report on Thursday, October 2nd. Truist Financial decreased their target price on UiPath from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Friday, September 5th. Finally, Canaccord Genuity Group decreased their target price on UiPath from $16.00 to $15.00 and set a "buy" rating for the company in a research report on Monday, September 8th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, twelve have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $13.21.
View Our Latest Stock Report on UiPath
UiPath Company Profile
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.